CH516576A - Cns-depressant anticonvulsant tetrahydro- - Google Patents

Cns-depressant anticonvulsant tetrahydro-

Info

Publication number
CH516576A
CH516576A CH607971A CH607971A CH516576A CH 516576 A CH516576 A CH 516576A CH 607971 A CH607971 A CH 607971A CH 607971 A CH607971 A CH 607971A CH 516576 A CH516576 A CH 516576A
Authority
CH
Switzerland
Prior art keywords
tetrahydro
formula
methyl
thiophene
base
Prior art date
Application number
CH607971A
Other languages
French (fr)
Inventor
John Tinney Francis
Original Assignee
Parke Davis & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parke Davis & Co filed Critical Parke Davis & Co
Priority claimed from CH166970A external-priority patent/CH513201A/en
Publication of CH516576A publication Critical patent/CH516576A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/36Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/42Singly bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/92Naphthofurans; Hydrogenated naphthofurans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/08Hydrogen atoms or radicals containing only hydrogen and carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/58Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/66Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/74Naphthothiophenes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08Six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/0008Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
    • C08K5/005Stabilisers against oxidation, heat, light, ozone

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

CNS-depressant anticonvulsant tetrahydrobenzothienodiazepinones 6,7,8,9-Tetrahydro-5-Ar-1-R1-1H- 1 benzothieno 2,3-e 1,4 diazepin-2(3H)-ones, where Ar is Ph, o-F/Cl-Ph or 2-thienyl; R1 is H or Me are CNS-depressants & anticonvulsants.

Description

  

  Procédé de préparation d'un tétrahydrobenzothiénodiazépinone    La présente invention a pour objet un procédé de  préparation de nouveaux composés azotés     hétérocycli-          ques    qui sont     utiles    comme agents     pharmacologiques,     préparation qui aboutit à de nouvelles     tétrahydrobenzo-          thiénodiazépinones    de formule  
EMI0001.0006     
    dans  et de leurs sels pharmaceutiquement acceptables: dans  cette formule, Ri est un atome d'hydrogène ou un groupe  méthyle et Ar est un groupe phényle, o-fluorophényle,  o-chlorophényle ou 2-thiényle.  



  Conformément à l'invention, on prépare des     tétra-          hydrobenzothiénodiazépinones    de formule I ci-dessus en  faisant réagir un .sel de     2-(2-aminoacétamido)-3-aroyl-          tétrahydrobenzothiophène    de formule       c'est-à-dire    2  
EMI0001.0012     
    avec une quantité de basa suffisante pour neutraliser le       le        -(2-aminoacéta-          sel,    puis las base libre, c'est-à-dire le     2(2-aminoacéta-          mido)-3-aroyltétrahydrobenzothiophène    libéré,

   subit une    cyclisation pour donner une     tétrahydrobenzothiénodiazé-          pinone    de formule I ; dans cette formule, R1 et Ar ont  la     signification    ci-dessus et A représente un équivalent  d'un anion. De     préférence,    on conduit la réaction     dans     un milieu solvant, qui peut être l'eau ou un alcanol infé  rieur aqueux.

   On peut     utiliser    un grand nombre de bases,  y     compris    des carbonates et des bicarbonates de     métal          alcalin,    tels que le carbonate de sodium, le     carbonate    de  des hydroxydes  potassium et le     bicarbonate    de  de métal alcalin tels que l'hydroxyde de sodium et l'hy  droxyde de potassium ; et des hydroxydes de métal       alcalino-terreux,    tels que l'hydroxyde de magnésium. La  base préférée est un hydroxyde de métal     alcalin    aqueux.  La température n'est pas critique et on peut conduire la  réaction à la température ordinaire, c'est-à-dire sans  chauffage ou refroidissement extérieur.

   La durée de la  réaction n'est pas critique non plus, mais dépend dans  une certaine mesure de la     quantité    de base utilisée. On  obtient une réaction rapide et les meilleurs résultats lors  qu'on rend le mélange réactionnel fortement basique  (pH 10-l2).  



  On prépare de diverses     manières    les sels de     2-(2-          aminoacétamido)    - 3 - aroyltétrahydrobenzothiophène     né-          de    départ pour le procédé ci  cessaires comme  dessus.

   On prépare par exemple les bromhydrates, qui  sont les matières de départ préférées par réaction d'un  2 - amino - 3 - aroyltétrahydrobenzothiophène de formule  
EMI0001.0037     
      avec la N-(carbobenzoxy)glycine en présence de     N,N'-          dicyclohexylcarbodiimide    pour obtenir un 3-aroyl-2-         [2-(carbobenzoxyamino)-acétamido]tétrahydrobenzothio-          phène    de formule  
EMI0002.0004     
    qu'on fait     alors    réagir avec l'acide bromhydrique dans  de l'acide acétique pour obtenir le bromhydrate,     c'est-          à-dire    la matière de départ     désirée    (formule II, A = Br).

    On peut alors     obtenir    d'autres sels, si on le  à partir  du bromhydrate par échange d'anion sur une résine  échangeuse d'ion appropriée.  



  On peut     aussi    préparer les     chlorhydrates    de 2-(2  aminoacétamido)-3-aroyltétrahydrobenzothiophène par la  réaction d'un     3-aroyl-2-(2-azidoacétamido)tétrahydro-          benzothiophène    de formule:  le prépare  
EMI0002.0014     
    base;  toluène;

    avec du chlorure stanneux et de l'acide chlorhydrique  dans un milieu solvant non réactif, tel que le     tétrahydro-          furanne.    Lorsqu'on le prépare ainsi, le mieux est de faire  réagir le     chlorhydrate,    c'est-à-dire la matière de départ,       obtenue    directement,     avec    une base comme     décrit    plus  haut sans isolement.  



  On peut préparer les     tétrahydrobenzothiénodiazépi-          nones    de formule:  
EMI0002.0023     
    en faisant réagir une tétrahydrobenzothiénodiazépinone  de formule  
EMI0002.0024     
    obtenue selon le présent procédé avec un agent de     méthy-          lation    en présence d'une base; dans cette formule Ar a  la même     signification    que plus haut. Des exemples  d'agents de méthylation qu'on peut utiliser sont un  halogénure de méthyle, surtout l'iodure de méthyle, le  sulfate de méthyle et un hydrocarbure sulfonate de mé  thyle, tel que le méthanesulfonate de méthyle et le  p-toluènesulfonate de méthyle.

   Les bases qu'on peut uti  liser incluent des     hydrures    de     métal        alcalin,    tels que  l'hydrure de sodium et l'hydrure de lithium, des     ami-          dures    de métal alcalin, tels que l'amidure de sodium et  l'amidure de potassium, et des alcoxydes de métal alca  lin.     Parmi        ceux-ci,    c'est l'hydrure de sodium qu'on pré  fère.

   II est préférable de     conduire    la réaction dans un  milieu solvant non réactif> qui peut être un amide ter  tiaire tel que le N,N-diméthylformamide, le     N,N-dimé-          thylacétamide    et la N-méthyl-2-pyrrolidinone ; un éther,  tel que le diéthyléther, le tétrahydrofuranne et le     dioxan-          ne    ; un hydrocarbure aromatique, tel que le benzène et  le toulène; le sulfoxyde de diméthyle ; et leurs mélanges.  



  Les solvants préférés sont le N,N-diméthylformamide et  le sulfoxyde diméthyle. La température et la durée de  la     réaction    ne     sont    pas critiques et peuvent varier forte  ment, la température de 0 à     100    C et la durée de 1 à  environ 48 heures.

   On peut conduire la réaction à la       température    ordinaire, c'est-à-dire sans chauffage ou re  froidissement extérieur> et à cette température la réaction  est pratiquement     complète    après environ 1 à 4 heures,  mais on peut.     facultativement    la poursuivre pendant jus  qu'à 16 heures pour s'assurer qu'elle soit     complète.    On  peut     utiliser    des quantité     équimolaires    des réactifs et de  la     base,    bien     qu'un    léger     excès    d'un d'entre eux ne soit       pas    nuisible.

   Pour des rendements optimum, il est avan  tageux d'utiliser un léger excès de l'agent de méthylation  et de la     base.     



  Ces     composés    peuvent exister sous leur forme libre  de     formule    I     ci-dessus    ou sous forme d'un sel d'addition  d'acide. On forme des sels d'addition d'acide     pharmaceu-          tiquement    acceptables par la réaction de la     tétrahydro-          benzothiénodiazépinone    libre avec un grand nombre       d'acides        inorganiques,    y     compris    l'acide chlorhydrique,  bromhydrique,     iodhydrique,        nitrique,    sulfurique et phos  phorique,

   et avec     certains    acides organiques forts, tels  que l'acide méthanesulfonique, benzènesulfonique et     p-          toluënesulfonique.     



  Les tétrahydrobenzothiénodiazépinones libres de for  mule I dans laquelle     Rl    est     un    atome d'hydrogène for  ment aussi des sels     pharmaceutiquement        acceptables    par  réaction avec une base forte. Des bases     fortes    appropriées  à ce but incluent des     hydroxydes    de métal     alcalin,    tels  que l'hydroxyde de sodium, l'hydroxyde de potassium et  l'hydroxyde de lithium ; des hydrures de     métal        alcalin,         tels que l'hydrure de sodium ; des alcoxydes de métal  alcalin ; et des hydroxydes de métal     alcalino-terreux.     



  Les tétrahydrobenzothiénodiazépinones libres et leurs  sels peuvent avoir     certaines    propriétés physiques sensi  blement différentes, telles que la     solubilité    dans des sol  vants polaires, mais sont équivalents par ailleurs pour les  buts de l'invention.  



  Ces composés sont des nouveaux composés chimiques  qui sont     utiles    comme agents pharmacologiques. Comme  tels, ils ont un effet dépressif sur le sytème nerveux cen  tral, qui est indiqué par leur pouvoir d'empêcher l'ap  parition de     convulsions    chez des animaux de laboratoire  après l'administration de pentaméthylènetétrazole et  aussi par leur pouvoir de surmonter un comportement  inhibé chez les animaux placés dans une situation pro  duisant l'angoisse.  



  <I>Exemple I</I>  On     alcalinise        fortement    une solution de 10g de  bromhydrate de     2-(2-amino-N-méthylacétamido)-3-ben-          zoyl-4,5,6,7-tétrahydrobenzo[b]thiophène    dans 100 ml  d'eau à la température ordinaire par l'addition d'hy  droxyde de sodium aqueux à 50 0/0, et extrait le mélange  obtenu plusieurs fois avec du dichlorométhane.

   On lave  à l'eau les extraits     réunis,    les sèche et les évapore sous  pression réduite pour obtenir la     6,7,8,9-tétrahydro-1-          méthyl-5-phényl-1H-    [1]benzothiéno[2,3-e]     [1,4]diazépin-          2(3H)-one    qui fond à 129-131C après cristallisation  dans l'hexane.  



  On dissout 2,5 g de la base libre obtenue dans 20 ml  d'acide chlorhydrique éthanolique à 5 %, refroidit la  solution obtenue à     0,1    C,     puis    isole, lave à l'éther et sèche  le monochlorhydrate de     6,7,8,9-tétrahydro-1-méthyl-5-          phényl-1H-[1]benzothiéno[2,3-e][1,4]diazépin-2(3H)-one     qui précipite.  



  <I>Exemple 2</I>  La matière de départ peut être obtenue comme suit  A une solution agitée de 42 g de chlorure stanneaux  dihydraté dans 100 ml d'acide chlorhydrique concentré  à 5 à 100 C on ajoute par portions 32 g de     3-benzoyl-2-          (2-azidoacétamido)-4,5,6,7-tétrahydrobenzo    [b]thiophène.  Lorsque l'addition est complète, on ajoute 100 ml de  tétrahydrofuranne et agite et chauffe le mélange obtenu  à 600 C jusqu'à ce que le dégagement d'azote cesse. On  refroidit alors le mélange, qui contient le chlorhydrate  de 3-benzoyl-2-(2 - aminoacétamido) - 4,5,6,7-     tétrahydro-          benzo[b]thiophène,    et le dilue avec un volume égal d'eau,  puis extrait le mélange aqueux au dichlorométhane.  



  Pour la mise en ouvre du procédé, on lave l'extrait  deux fois avec de l'hydroxyde de sodium aqueux dilué,  le sèche, le traite avec du charbon, le filtre et l'évapore  à sec. On extrait le résidu obtenu avec de l'acide chlor  hydrique dilué et     alcalinise    l'extrait acide avec un     excès     d'ammoniac aqueux pour précipiter un solide gommeux  qu'on isole et cristallise dans l'acétonitrile. C'est la  6,7,8,9 -tétrahydro- 5 -phényl -1H-     [1]benzothiéno[2,3-e]-          [1,4]diazépin-2(3H)-one    qui fond à 249-2500 C.  



  On peut obtenir le sel de sodium du produit     ci-          dessus    comme suit: on agite 5,9g de la     6,7,8,9-tétra-          hydro    - 5 - phényl -1H- [ 1]benzothiéno[2,3-e]     [1,4]diazépin-          2(3H)-one    avec 40 ml d'hydroxyde de sodium 0,5N,  filtre le mélange obtenu et lyophilise le filtrat.

   On dis  sout le résidu solide obtenu dans 30 ml de     N,N-diméthyl-          formamide    chaud et filtre la solution, la refroidit et la  traite avec environ 100 ml d'éther pour précipiter le sel    de sodium de la     6,7,8,9-tétrahydro-5-phényl-1H-[1]benzo-          thiéno[2,3-e][1,4]diazépin-2(3H)-one    qu'on isole, lave à  l'éther et sèche.  



  Ce produit peut être méthylé comme suit  A une solution agitée de 5,0 g de     6,7,8,9-tétrahydro-          5-phényl-1H-        [1]benzothiéno[2,3-e][1,4]diazépin-2(3H)-          one    ainsi obtenue dans 200 ml de     N,N-diméthylforma-          mide    on ajoute par. portions 0,78 g d'hydrure de sodium  à 60,2 0/o en disprsion dans une huile minérale. On  refroidit à 100 C la suspension obtenue, ajoute goutte  à goutte 2,8 g d'iodure de méthyle, puis agite le mélange  obtenu à la température ordinaire pendant environ 45 mi  nutes.

   On l'évapore alors sous pression réduite, dissout le  résidu obtenu dans 100 ml de dichlorométhane et lave  la solution obtenue avec deux portions de 100     ml    d'eau,  la sèche et l'évapore sous pression réduite pour obtenir  la     6,7,8,9-tétrahydro-1-méthyl-5-phényl-1H-[1]benzo-          thiéno[2,3-e][1,4]diazépin-2(3H)-one    qu'on isole et puri  fie par cristallisation dans l'hexane, elle fond à 129  131o C.  



  <I>Matières de départ</I>  On peut obtenir les diverses matières de départ utili  sées dans les exemples ci-dessus et les produits intermé  diaires nécessaires à leur préparation par les méthodes  décrites ci-dessous.  



  A) Le     3-benzoyl-2-(2-bromoacétamido)-4,5,6,7-tétra-          hydrobenzo    [b]thiophène.  



  A une solution agitée de 23 g de     2-amino-3-benzoyl-          4,5,6,7-tétrahydrobenzo[b]thiophène    (pour la préparation  de ce composé et des composés apparentés voir       Che-          mische    Berichte  , vol.

   98, pages 3571-3577 (1965)) et  7,1 g de pyridine dans 1000 ml d'éther on ajoute goutte  à goutte 21,6 g de bromure de bromo-acétyle, et agite  le mélange obtenu à la température ordinaire pendant  3     heures.    On le traite alors avec environ 150 ml d'eau,  et sépare la phase organique, la lave avec deux     portions     de 200 ml d'eau, la sèche et l'évapore pour obtenir  le     3-benzoyl-2-(2-bromoacétamido)-4,5,6,7-tétrahydro-          benzo[b]thiophène    désiré qui fond à 109-1110C après  cristallisation dans du méthanol.  



  B) Le bromhydrate de     2-(2-amino-N-méthylacéta-          mido)-3-benzoyl-4,5,6,7-tétrahydrobenzo    [b]thiophène.  



  On agite un mélange qui consiste en 10,1 g de  2-amino-3-benzoyl-4,5,6,7-tétrahydrobenzo[b]thiophène,  8,5 g de chlorure de p-toluènesulfonyle et 150 ml de  pyridine et le chauffe au reflux pendant 90 minutes, le  refroidit et le dilue avec 300 ml d'eau glacée pour obtenir  un précipité solide de     3-benzoyl-4,5,6,7-tétrahydro-2-(p-          toluènesulfonamido)benzo[b]thiophène,    qu'on isole, lave  à l'eau, sèche et     utilise    pour le stade réactionnel suivant  sans autre purification.  



  A un mélange agité de 2,0 g d'hydrure de sodium à  50     Vo    en dispersion dans une huile minérale et 30 ml  de N,N-diméthylformamide à 20-25 C on ajoute par  portions 14,5 g de     3-benzoyl-4,5,6,7-tétrahydro-2-(p-to-          luènesulfonamido)benzo[b]thiophène.    On agite le mé  lange obtenu pendant 30 minutes, ajoute goutte à goutte  8,8 g de sulfate de diméthyle, puis agite le mélange réac  tionnel pendant encore 2 heures à 20-250 C. On l'éva  pore alors sous pression réduite et extrait le résidu obtenu  au dichlorométhane.

   On lave la solution de     dichloro-          méthane    successivement avec de l'eau, de l'hydroxyde  de sodium aqueux à 4 0/o et du chlorure de sodium  aqueux saturé, la sèche et l'évapore pour obtenir le 3-ben  zoyl-4,5,6,7-tétrahydro-2-(N-méthyl-p-toluènesulfonami-      do)benzo[b]thiophène, pouvant être utilisé sans autre     pu-          rification.     



  On agite un mélange qui consiste en 2,3 g de sodium,  13 g de naphtalène et 150 ml de 1,2-diméthoxyéthane  sous de     l'azote    à     20-25    C     pendant    90     minutes.    A la  solution obtenue on ajoute une solution de 12,8 g  de 3 - benzoyl - 4,5,6,7-     tétrahydro-2-(N-méthyl-p-toluène-          sulfonamido)benzo[b]thiophène    dans 100 ml de     1,2-di-          méthoxyéthane    et agite le mélange réactionnel à 20-250 C       pendant    2 heures.

   On le traite alors, avec précaution,  avec 35     ml    d'eau et le dilue avec 250 mi     d'acétate          d'éthyle.   <B>On</B> sépare la phase organique, la lave avec du  chlorure de     sodium    aqueux saturé et l'extrait avec 200 ml  d'acide     chlorhydrique    1 N.

   On     alcalinise    ensuite l'extrait  acide avec<B>de</B> l'hydroxyde de sodium aqueux à 30 % et  extrait le mélange basique à     l'éther.    On lave l'extrait  éthérique à l'eau, le sèche et l'évapore pour obtenir  le     3-benzoyl-4,5,6,7-tétrahydro-2-(méthylamino)benzo[b]-          thiophène,    qu'on peut utiliser pour la réaction suivante       sans    autre     purification.     



  A une solution de 23,3 g du produit     intermédiaire    ci  dessus dans 300     ml        d'acétate    d'éthyle on ajoute 15 g  de N-(carbobenzoxy)glycine et 16 g de     N,N'-dicyclohexyl-          carbodiimide    et agite et chauffe au reflux pendant  16 heures le mélange     obtenu.    On le refroidit alors et le  filtre pour enlever la N,N-dicyclohexylurée insoluble pré  cipitée,     c'est-à-dire    le sous-produit, et lave le filtrat avec  du     bicarbonate    de sodium aqueux     dilué    et avec de l'acide  chlorhydrique dilué.

   Après séchage, on l'évapore sous  pression réduite pour obtenir le     3-benzoyl-2-[2-(carbo-          benzoxyamino)    -N-méthylacétamido]     -4,5,6,7-tétrahydro-          benzo[b]thiophène,    qu'on peut purifier par cristallisation  dans de     l'acétate    d'éthyle/éther de pétrole.  



  On     dissout    les 20 g de produit intermédiaire précédent       dans    200 ml d'acide bromhydrique à 20 %     dans    l'acide       acétique    et maintient la solution obtenue à 20-250 C pen  dant 2 heures. On la verse alors dans 1000 ml d'éther et  isole le bromhydrate de     2-(2-amino-N-méthylacétamido)-          3-benzoyl-4,5,6,7-tétrahydrobenzo[b]thiophène    solide qui  précipite, le lave à l'eau et le     sèche.     



  C) Le     3-benzoyl-2-(2-azidoacétamido)-4,5,6,7-tétra-          hydrobenzo[b]thiophène.     



  A une suspension     agitée    de 18 g d'azoture de sodium  dans 100 ml de sulfoxyde de diméthyle on ajoute 75 g  de     3-benzoyl-2-(2-bromoacétamido)-4,5,6,7-tétrahydro-          benzo[b]thiophène    et agite le mélange obtenu pendant  une heure en maintenant la température en dessous de       4(M    C au moyen d'un bain de refroidissement     externe.     On le verse     alors    dans 400 ml d'eau froide et isole le  solide gommeux qui     précipite.    Après avoir trituré la  gomme avec de l'éther, on obtient le     3-benzoyl-2-(2-azi-          doacétamido)-4,5,6,

  7-tétrahydrobenzo[b]thiophène    cris  tallin qu'on isole et sèche, il fond à 119-1240 C.



  Process for preparing a tetrahydrobenzothienodiazepinone The present invention relates to a process for preparing novel heterocyclic nitrogen compounds which are useful as pharmacological agents, which preparation results in novel tetrahydrobenzothienodiazepinones of formula
EMI0001.0006
    in and their pharmaceutically acceptable salts: in this formula, R 1 is a hydrogen atom or a methyl group and Ar is a phenyl, o-fluorophenyl, o-chlorophenyl or 2-thienyl group.



  In accordance with the invention, tetrahydrobenzothienodiazepinones of formula I above are prepared by reacting a 2- (2-aminoacetamido) -3-aroyl-tetrahydrobenzothiophene salt of formula that is to say 2
EMI0001.0012
    with a sufficient quantity of basa to neutralize the le - (2-aminoacetal salt, then the free base, that is to say the 2 (2-aminoacetamido) -3-aroyltetrahydrobenzothiophene released,

   undergoes cyclization to give a tetrahydrobenzothienodiazepinone of formula I; in this formula, R1 and Ar have the above meaning and A represents an equivalent of an anion. Preferably, the reaction is carried out in a solvent medium, which may be water or an aqueous lower alkanol.

   A large number of bases can be used, including alkali metal carbonates and bicarbonates, such as sodium carbonate, potassium hydroxide carbonate, and alkali metal bicarbonate such as sodium hydroxide and sodium hydroxide. potassium hydroxide; and alkaline earth metal hydroxides, such as magnesium hydroxide. The preferred base is an aqueous alkali metal hydroxide. The temperature is not critical and the reaction can be carried out at room temperature, i.e. without external heating or cooling.

   The duration of the reaction is not critical either, but depends to some extent on the amount of base used. Rapid reaction and best results are obtained when the reaction mixture is made strongly basic (pH 10-12).



  The salts of 2- (2-aminoacetamido) - 3-aroyltetrahydrobenzothiophene necessary for the above process are prepared in various ways as above.

   For example, hydrobromides, which are the preferred starting materials, are prepared by reacting a 2 - amino - 3 - aroyltetrahydrobenzothiophene of the formula
EMI0001.0037
      with N- (carbobenzoxy) glycine in the presence of N, N'-dicyclohexylcarbodiimide to obtain a 3-aroyl-2- [2- (carbobenzoxyamino) -acetamido] tetrahydrobenzothiophene of formula
EMI0002.0004
    which is then reacted with hydrobromic acid in acetic acid to obtain the hydrobromide, i.e. the desired starting material (formula II, A = Br).

    Other salts can then be obtained, if they are obtained from the hydrobromide by anion exchange on a suitable ion exchange resin.



  It is also possible to prepare the hydrochlorides of 2- (2 aminoacetamido) -3-aroyltetrahydrobenzothiophene by the reaction of a 3-aroyl-2- (2-azidoacetamido) tetrahydro-benzothiophene of the formula: the prepares
EMI0002.0014
    based; toluene;

    with stannous chloride and hydrochloric acid in a non-reactive solvent medium, such as tetrahydrofuran. When prepared in this way, it is best to react the hydrochloride, i.e. the starting material, obtained directly, with a base as described above without isolation.



  Tetrahydrobenzothienodiazepinones of the formula can be prepared:
EMI0002.0023
    by reacting a tetrahydrobenzothienodiazepinone of the formula
EMI0002.0024
    obtained according to the present process with a methylating agent in the presence of a base; in this formula Ar has the same meaning as above. Examples of methylating agents which can be used are a methyl halide, especially methyl iodide, methyl sulfate, and a methyl hydrocarbon sulfonate, such as methyl methanesulfonate and methyl p-toluenesulfonate. .

   Bases which can be used include alkali metal hydrides, such as sodium hydride and lithium hydride, alkali metal amides, such as sodium amide and potassium amide. , and alca lin metal alkoxides. Of these, sodium hydride is preferred.

   It is preferable to carry out the reaction in a non-reactive solvent medium which may be a tertiary amide such as N, N-dimethylformamide, N, N-dimethylacetamide and N-methyl-2-pyrrolidinone; an ether, such as diethyl ether, tetrahydrofuran and dioxane; an aromatic hydrocarbon, such as benzene and toulene; dimethyl sulfoxide; and their mixtures.



  The preferred solvents are N, N-dimethylformamide and dimethyl sulfoxide. The reaction temperature and time are not critical and can vary widely, the temperature from 0 to 100 C and the time from 1 to about 48 hours.

   The reaction can be carried out at room temperature, that is, without external heating or cooling, and at this temperature the reaction is almost complete after about 1 to 4 hours, but it is possible. optionally continue for up to 4 p.m. to ensure it is complete. Equimolar amounts of the reagents and the base can be used, although a slight excess of either will not be detrimental.

   For optimum yields it is advantageous to use a slight excess of the methylating agent and the base.



  These compounds can exist in their free form of formula I above or as an acid addition salt. Pharmaceutically acceptable acid addition salts are formed by the reaction of free tetrahydro-benzothienodiazepinone with a large number of inorganic acids, including hydrochloric, hydrobromic, hydriodic, nitric, sulfuric and phos phoric acid,

   and with certain strong organic acids, such as methanesulfonic acid, benzenesulfonic acid and p-toluensulfonic acid.



  The free tetrahydrobenzothienodiazepinones of formula I in which R1 is a hydrogen atom also form pharmaceutically acceptable salts by reaction with a strong base. Strong bases suitable for this purpose include alkali metal hydroxides, such as sodium hydroxide, potassium hydroxide, and lithium hydroxide; alkali metal hydrides, such as sodium hydride; alkali metal alkoxides; and alkaline earth metal hydroxides.



  The free tetrahydrobenzothienodiazepinones and their salts may have certain significantly different physical properties, such as solubility in polar solvents, but are otherwise equivalent for the purposes of the invention.



  These compounds are new chemical compounds which are useful as pharmacological agents. As such, they have a depressive effect on the central nervous system, which is indicated by their power to prevent the onset of convulsions in laboratory animals after administration of pentamethylenetetrazole and also by their power to overcome behavior. inhibited in animals placed in an anxiety-producing situation.



  <I> Example I </I> A solution of 10g of 2- (2-amino-N-methylacetamido) -3-ben-zoyl-4,5,6,7-tetrahydrobenzo [b] thiophene hydrobromide solution is strongly alkalized in 100 ml of water at room temperature by adding 50% aqueous sodium hydroxide, and extract the mixture obtained several times with dichloromethane.

   The combined extracts are washed with water, dried and evaporated under reduced pressure to give 6,7,8,9-tetrahydro-1-methyl-5-phenyl-1H- [1] benzothieno [2,3- e] [1,4] diazepin- 2 (3H) -one which melts at 129-131C after crystallization from hexane.



  2.5 g of the free base obtained are dissolved in 20 ml of 5% ethanolic hydrochloric acid, the solution obtained is cooled to 0.1 C, then isolated, washed with ether and the 6.7 monohydrochloride dried, 8,9-Tetrahydro-1-methyl-5-phenyl-1H- [1] benzothieno [2,3-e] [1,4] diazepin-2 (3H) -one which precipitates.



  <I> Example 2 </I> The starting material can be obtained as follows To a stirred solution of 42 g of stanneaux chloride dihydrate in 100 ml of concentrated hydrochloric acid at 5 to 100 C is added in portions 32 g of 3 -benzoyl-2- (2-azidoacetamido) -4,5,6,7-tetrahydrobenzo [b] thiophene. When the addition is complete, 100 ml of tetrahydrofuran are added and the mixture obtained is stirred and heated at 600 ° C. until the evolution of nitrogen ceases. The mixture, which contains 3-benzoyl-2- (2-aminoacetamido) - 4,5,6,7-tetrahydro-benzo [b] thiophene hydrochloride, is then cooled, and diluted with an equal volume of water, then extract the aqueous mixture with dichloromethane.



  To carry out the process, the extract is washed twice with dilute aqueous sodium hydroxide, dried, treated with charcoal, filtered and evaporated to dryness. The residue obtained is extracted with dilute hydrochloric acid and the acid extract is made basic with an excess of aqueous ammonia to precipitate a gummy solid which is isolated and crystallized from acetonitrile. It is 6,7,8,9 -tetrahydro- 5 -phenyl -1H- [1] benzothieno [2,3-e] - [1,4] diazepin-2 (3H) -one which melts at 249- 2500 C.



  The sodium salt of the above product can be obtained as follows: 5.9g of 6,7,8,9-tetrahydro - 5 - phenyl -1H- [1] benzothieno [2,3-e ] [1,4] diazepin- 2 (3H) -one with 40 ml of 0.5N sodium hydroxide, filter the mixture obtained and lyophilize the filtrate.

   The solid residue obtained is dissolved in 30 ml of hot N, N-dimethylformamide and the solution filtered, cooled and treated with about 100 ml of ether to precipitate the sodium salt of 6,7,8, 9-tetrahydro-5-phenyl-1H- [1] benzothieno [2,3-e] [1,4] diazepin-2 (3H) -one which is isolated, washed with ether and dried.



  This product can be methylated as follows To a stirred solution of 5.0 g of 6,7,8,9-tetrahydro-5-phenyl-1H- [1] benzothieno [2,3-e] [1,4] diazepin -2 (3H) - one thus obtained in 200 ml of N, N-dimethylformamide is added by. portions 0.78 g of sodium hydride at 60.2 0 / o in disprsion in mineral oil. The suspension obtained is cooled to 100 ° C., 2.8 g of methyl iodide are added dropwise, then the mixture obtained is stirred at room temperature for about 45 minutes.

   It is then evaporated off under reduced pressure, the residue obtained is dissolved in 100 ml of dichloromethane and the solution obtained is washed with two portions of 100 ml of water, dried and evaporated under reduced pressure to obtain 6,7,8 , 9-tetrahydro-1-methyl-5-phenyl-1H- [1] benzothieno [2,3-e] [1,4] diazepin-2 (3H) -one which is isolated and purified by crystallization in hexane it melts at 129,131o C.



  <I> Starting materials </I> The various starting materials used in the examples above and the intermediate products necessary for their preparation can be obtained by the methods described below.



  A) 3-Benzoyl-2- (2-bromoacetamido) -4,5,6,7-tetrahydrobenzo [b] thiophene.



  To a stirred solution of 23 g of 2-amino-3-benzoyl-4,5,6,7-tetrahydrobenzo [b] thiophene (for the preparation of this compound and related compounds see Che- mische Berichte, vol.

   98, pages 3571-3577 (1965)) and 7.1 g of pyridine in 1000 ml of ether are added dropwise 21.6 g of bromo-acetyl bromide, and the resulting mixture is stirred at room temperature for 3 hours. It is then treated with about 150 ml of water, and the organic phase is separated, washed with two portions of 200 ml of water, dried and evaporated to obtain 3-benzoyl-2- (2-bromoacetamido) -4,5,6,7-tetrahydro-benzo [b] thiophene desired which melts at 109-1110C after crystallization from methanol.



  B) 2- (2-Amino-N-methylacetamido) -3-benzoyl-4,5,6,7-tetrahydrobenzo [b] thiophene hydrobromide.



  A mixture which consists of 10.1 g of 2-amino-3-benzoyl-4,5,6,7-tetrahydrobenzo [b] thiophene, 8.5 g of p-toluenesulfonyl chloride and 150 ml of pyridine and reflux it for 90 minutes, cool it and dilute it with 300 ml of ice-water to obtain a solid precipitate of 3-benzoyl-4,5,6,7-tetrahydro-2- (p-toluenesulfonamido) benzo [b ] thiophene, which is isolated, washed with water, dried and used for the next reaction stage without further purification.



  To a stirred mixture of 2.0 g of 50 Vo sodium hydride dispersed in mineral oil and 30 ml of N, N-dimethylformamide at 20-25 C, 14.5 g of 3-benzoyl- are added in portions. 4,5,6,7-Tetrahydro-2- (p-toluenesulfonamido) benzo [b] thiophene. The mixture obtained is stirred for 30 minutes, 8.8 g of dimethyl sulfate is added dropwise, then the reaction mixture is stirred for a further 2 hours at 20-250 C. It is then evaporated under reduced pressure and extracted. the residue obtained with dichloromethane.

   The dichloromethane solution is washed successively with water, 40% aqueous sodium hydroxide and saturated aqueous sodium chloride, dried and evaporated to give 3-ben zoyl-4. , 5,6,7-tetrahydro-2- (N-methyl-p-toluenesulfonamide) benzo [b] thiophene, which can be used without further purification.



  A mixture which consists of 2.3 g of sodium, 13 g of naphthalene and 150 ml of 1,2-dimethoxyethane is stirred under nitrogen at 20-25 C for 90 minutes. To the solution obtained is added a solution of 12.8 g of 3 - benzoyl - 4,5,6,7-tetrahydro-2- (N-methyl-p-toluene-sulfonamido) benzo [b] thiophene in 100 ml of 1,2-di-methoxyethane and stir the reaction mixture at 20-250 C for 2 hours.

   It is then treated carefully with 35 ml of water and diluted with 250 ml of ethyl acetate. <B> The </B> organic phase is separated, washed with saturated aqueous sodium chloride and extracted with 200 ml of 1 N hydrochloric acid.

   The acid extract is then basified with <B> 30% aqueous sodium hydroxide and the basic mixture is extracted with ether. The ether extract is washed with water, dried and evaporated to give 3-benzoyl-4,5,6,7-tetrahydro-2- (methylamino) benzo [b] - thiophene, which can be obtained. use for the next reaction without further purification.



  To a solution of 23.3 g of the above intermediate product in 300 ml of ethyl acetate are added 15 g of N- (carbobenzoxy) glycine and 16 g of N, N'-dicyclohexyl-carbodiimide and stir and heat with reflux for 16 hours the mixture obtained. It is then cooled and filtered to remove the precipitated insoluble N, N-dicyclohexylurea, i.e. the by-product, and the filtrate washed with dilute aqueous sodium bicarbonate and with dilute hydrochloric acid. .

   After drying, evaporated under reduced pressure to obtain 3-benzoyl-2- [2- (carbobenzoxyamino) -N-methylacetamido] -4,5,6,7-tetrahydro-benzo [b] thiophene, which It can be purified by crystallization from ethyl acetate / petroleum ether.



  The 20 g of the above intermediate product are dissolved in 200 ml of 20% hydrobromic acid in acetic acid and the solution obtained is maintained at 20-250 C for 2 hours. It is then poured into 1000 ml of ether and the solid 2- (2-amino-N-methylacetamido) - 3-benzoyl-4,5,6,7-tetrahydrobenzo [b] thiophene hydrobromide is isolated, which precipitates, washed. with water and dry it.



  C) 3-Benzoyl-2- (2-azidoacetamido) -4,5,6,7-tetrahydrobenzo [b] thiophene.



  To a stirred suspension of 18 g of sodium azide in 100 ml of dimethyl sulfoxide is added 75 g of 3-benzoyl-2- (2-bromoacetamido) -4,5,6,7-tetrahydro-benzo [b] thiophene and stir the mixture obtained for one hour while maintaining the temperature below 4 (MC by means of an external cooling bath. It is then poured into 400 ml of cold water and the gummy solid which precipitates is isolated. triturated the gum with ether, 3-benzoyl-2- (2-azidoacetamido) -4,5,6 is obtained,

  7-tetrahydrobenzo [b] thiophene cris tallin which is isolated and dried, it melts at 119-1240 C.

 

Claims (1)

REVENDICATION Procédé de préparation d'une tétrahydrobenzothiéno- diazépinone de formule EMI0004.0056 caractérisé en ce qu'on fait réagir un sel de 2-(2-amino- acétamido)-3-aroyltétrahydrobenzothiophène de formule ou A représente un équivalent d'un anion. CLAIM Process for preparing a tetrahydrobenzothienodiazepinone of formula EMI0004.0056 characterized in that a 2- (2-aminoacetamido) -3-aroyltetrahydrobenzothiophene salt of formula where A represents an equivalent of an anion is reacted. duquel R1 est un atome d'hydrogène, avec un agent de l u EMI0004.0059 avec une base ; dans ces formules R1 est un atome d'hy drogène ou un groupe méthyle, Ar est un groupe phé nyle, o-fluorophényle, o-chlorophényle 2-thiényle et SOUS-REVENDICATIONS 1. Procédé selon la revendication, caractérisé en ce que la base utilisée est un hydroxyde de métal alcalin aqueux. of which R1 is a hydrogen atom, with an agent of the u EMI0004.0059 with a base; in these formulas R1 is a hydrogen atom or a methyl group, Ar is a phenyl, o-fluorophenyl, o-chlorophenyl 2-thienyl group and SUB-CLAIMS 1. Process according to claim, characterized in that the base used is an aqueous alkali metal hydroxide. 2. Procédé selon la revendication, caractérisé en ce que l'on fait réagir un composé produit, dans la formule duquel R1 est un atome d'hydrogène, avec un agent de méthylation en présence d'une base pour produire un composé de même formule dans laquelle R1 est le groupe méthyle. 2. Method according to claim, characterized in that one reacts a product compound, in the formula of which R1 is a hydrogen atom, with a methylating agent in the presence of a base to produce a compound of the same formula in which R1 is methyl. 3. Procédé selon la sous-revendication 2, caractérisé en ce que l'agent de méthylation est un halogénure de méthyle et la base ti isée pour la méthylation est un hydrure de métal alcalin. 3. Method according to sub-claim 2, characterized in that the methylating agent is a methyl halide and the base ti ized for the methylation is an alkali metal hydride.
CH607971A 1969-02-06 1970-02-05 Cns-depressant anticonvulsant tetrahydro- CH516576A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79727469A 1969-02-06 1969-02-06
CH166970A CH513201A (en) 1967-04-21 1970-02-05 Process for preparing a tetrahydrobenzothienodiazepininone

Publications (1)

Publication Number Publication Date
CH516576A true CH516576A (en) 1971-12-15

Family

ID=25688338

Family Applications (1)

Application Number Title Priority Date Filing Date
CH607971A CH516576A (en) 1969-02-06 1970-02-05 Cns-depressant anticonvulsant tetrahydro-

Country Status (1)

Country Link
CH (1) CH516576A (en)

Similar Documents

Publication Publication Date Title
US5708020A (en) Arylalkyl(thio)amides
EP0373998B1 (en) Propenone oxime ethers, method for their preparation and pharmaceutical compositions containing them
FR2676054A1 (en) NOVEL N-ALKYLENEPIPERIDINO COMPOUNDS AND THEIR ENANTIOMERS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
CH404664A (en) Process for the preparation of new heterocyclic compounds
PT98100A (en) A process for the preparation of novel compounds of 4-amino-butyric acid and of pharmaceutical compositions containing the same
CA1294966C (en) Drivatives of 1h, 3h-prorrolo [1,2-c] thiazole, their preparation and pharmaceutical compositions containing them
EP0429344B1 (en) Pyridazine derivatives, process for their preparation and pharmaceutical compositions containing them
CH619463A5 (en)
KR19990036165A (en) Single Port Synthesis of 2-oxazolidinone Derivatives
EP0008249A2 (en) Fluorene and fluoranthene derivatives, process for their preparation and their therapeutic application
EP0002978B1 (en) Thiazolidinedione-2,4 derivatives, their preparation and pharmaceutical applications
CH641181A5 (en) INDOLO-QUINOLIZIDINES, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS CONTAINING THEM.
FR2477150A1 (en) NOVEL HETEROCYCLIC DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME
CH630606A5 (en) Phenylamidine derivatives useful especially in therapeutics
CH516576A (en) Cns-depressant anticonvulsant tetrahydro-
CA2010529A1 (en) 1-arylsulfonyl 2-piperidinone derivatives, process and intermediated for their preparation, use as medicaments and compositions containing them
NO124687B (en)
EP0000452A1 (en) 1,2,4-Oxadiazol derivatives, their preparation and application in pharmaceutical compositions
BE839365R (en) DIAZEPINE DERIVATIVES
CH620678A5 (en) Process for the preparation of a derivative of piperidine
EP0135406A1 (en) Pyrrolidinones potent on the central nervous system, process for their preparation and medicines containing them
DK156391B (en) ANALOGY PROCEDURE FOR PREPARING 3-AMINOPYR ROLLER DERIVATIVES
EP0009487B1 (en) New derivates from benzamide
JPH08502990A (en) Process for the preparation of enantiomerically pure 6-[(4-chlorophenyl) (1H-1,2,4-triazol-1-yl) methyl-1-methyl-1H-benzotriazole
CH667873A5 (en) N-IMIDAZOLIDINYLMETHYL BENZAMIDE DERIVATIVE.

Legal Events

Date Code Title Description
PL Patent ceased